FeesSafety
Pluang+

T3 Defense to launch new simulation products TOPS-NX Studio and SILOS at I/ITSEC 2026 in Orlando

Market News
03 Nov 2026, 16:10 WIB
GlobeNewsWire
View Source
Bullish
T3 Defense to launch new simulation products TOPS-NX Studio and SILOS at I/ITSEC 2026 in Orlando

T3 Defense's subsidiary, Tiltan Software Engineering, will debut two new physics-based simulation products, TOPS-NX Studio and SILOS, at the I/ITSEC 2026 conference in Orlando, Florida. These products enhance Tiltan's portfolio by enabling users to build and deploy synthetic environments for defense training and sensor development. The launch aims to expand Tiltan's reach from its Israeli base into the U.S. and allied defense markets, leveraging the world's largest modeling and simulation event to attract new customers and partners. This move supports T3 Defense's strategy to grow its defense technology offerings globally.

T3 Defense's new simulation products launch coincides with a Technology-sector market where 73 of 150 US stocks rose and 76 fell on Pluang. For readers following Technology stocks, here is Pluang's market snapshot as of Nov 03, 2026 19:43 WIB: GoPro Inc (GPRO) rose 6.25% to USD 1.01 with 95% buy orders and a typical hold time of 46 days; Gartner Inc (IT) fell 6.18% to USD 220.95 with 73% buy orders; Palantir Technologies Inc (PLTR) dropped 5.91% to USD 167.80 with 46% buy orders and an 80-day hold time.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
2 hours ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
2 hours ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
2 hours ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
3 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App